Related references
Note: Only part of the references are listed.Omega-3 index, obesity and insulin resistance in children
T. Burrows et al.
INTERNATIONAL JOURNAL OF PEDIATRIC OBESITY (2011)
Major Depressive Disorder Is Associated With Cardiovascular Risk Factors and Low Omega-3 Index
Thomas C. Baghai et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Omega-3 Index Correlates with Healthier Food Consumption in Adolescents and with Reduced Cardiovascular Disease Risk Factors in Adolescent Boys
Therese A. O'Sullivan et al.
LIPIDS (2011)
Omega-3 fatty acids modulate collagen signaling in human platelets
M. K. Larson et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2011)
The relation between the omega-3 index and arachidonic acid is bell shaped: Synergistic at low EPA plus DHA status and antagonistic at high EPA plus DHA status
Martine F. Luxwolda et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2011)
Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men
Catherine Calzada et al.
ATHEROSCLEROSIS (2010)
Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters
Gregory C. Shearer et al.
JOURNAL OF LIPID RESEARCH (2010)
Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids
Christophe Morisseau et al.
JOURNAL OF LIPID RESEARCH (2010)
Insights into the Mechanism of Binding of Arachidonic Acid to Mammalian 15-Lipoxygenases
Lea Toledo et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2010)
Red blood cells (RBCs), epoxyeicosatrienoic acids (EETs) and adenosine triphosphate (ATP)
Houli Jiang et al.
PHARMACOLOGICAL REPORTS (2010)
The Omega-3 Index: Clinical Utility for Therapeutic Intervention
William S. Harris
Current Cardiology Reports (2010)
Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity
Mahmoud Ebrahimi et al.
ACTA CARDIOLOGICA (2009)
Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung
Caroline Morin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Omega-3 polyunsaturated fatty acids and human health outcomes
Philip C. Calder et al.
BIOFACTORS (2009)
Omega-6 Fatty Acids and Risk for Cardiovascular Disease A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention
William S. Harris et al.
CIRCULATION (2009)
Increasing intakes of the long-chain ω-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men
Nicolas Guillot et al.
FASEB JOURNAL (2009)
Epoxyeicosatrienoic Acids Function as Selective, Endogenous Antagonists of Native Thromboxane Receptors: Identification of a Novel Mechanism of Vasodilation
David J. Behm et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Fatty Fish Intake Decreases Lipids Related to Inflammation and Insulin Signaling-A Lipidomics Approach
Maria Lankinen et al.
PLOS ONE (2009)
Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives
William S. Harris et al.
ATHEROSCLEROSIS (2008)
EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
Robert C. Block et al.
ATHEROSCLEROSIS (2008)
Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis
Karsten H. Weylandt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Functional vasodilation in the rat spinotrapezius muscle: Role of nitric oxide, prostanoids and epoxyeicosatrienoic acids
Lusha Xiang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
Cardiovascular risk and the omega-3 index
Clemens Von Schacky et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2007)
Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study
Michael H. Davidson et al.
CLINICAL THERAPEUTICS (2007)
Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids
Stephen Brunton et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators:: protectin D1 and 17S-hydroxy-DHA
Ana Gonzalez-Periz et al.
FASEB JOURNAL (2006)
Polyunsaturated fatty acids and inflammation
Philip C. Calder
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2006)
Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins
CN Serhan
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2005)
Regression to the mean: what it is and how to deal with it
AG Barnett et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2005)
The Omega-3 Index: a new risk factor for death from coronary heart disease?
WS Harris et al.
PREVENTIVE MEDICINE (2004)
Share Paper
